SCHEDULE: Vanguard Group Amends Significant Stake in STAAR Surgical Co

The Vanguard Group has updated its beneficial ownership in STAAR Surgical Co, reporting an 8.86% stake as of June 30, 2025.

Summary

• The Vanguard Group holds beneficial ownership of 4,390,767 shares of STAAR Surgical Co common stock.
• This ownership represents 8.86% of the total class of securities.
• Vanguard has sole dispositive power over 4,286,971 shares and shared dispositive power over 103,796 shares.
• Vanguard holds shared voting power over 53,426 shares and no sole voting power.
• The filing is an Amendment No. 7 to a Schedule 13G, indicating a routine update to a previously disclosed passive investment.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of STAAR Surgical Co.

Sentiment

Score: 5

Explanation: The filing is a routine beneficial ownership disclosure, providing factual information about an institutional investor's stake without indicating positive or negative operational or financial performance of the issuer.

Positives

• The Vanguard Group, a prominent institutional investor, maintains a substantial beneficial ownership stake of 8.86% in STAAR Surgical Co, which can be viewed as a sign of long-term confidence.
• Vanguard's certification confirms the investment is passive and held in the ordinary course of business, indicating no intent to disrupt company operations or control.

Negatives

• No specific negative information regarding STAAR Surgical Co's operations or financial performance is disclosed in this beneficial ownership filing.

Risks

• The filing itself does not detail specific risks related to STAAR Surgical Co's business operations or financial health.
• Vanguard's investment is passive, meaning they are not expected to actively intervene in company management or strategic decisions, which could be a risk if active shareholder engagement were desired by other investors.

Future Outlook

NA

Industry Context

This filing reflects a routine disclosure by a large asset manager, The Vanguard Group, regarding its passive investment in STAAR Surgical Co, consistent with its strategy of holding diversified portfolios across various industries. Such filings are standard for institutional investors crossing beneficial ownership thresholds.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional holding, potentially signaling long-term investor confidence due to Vanguard's reputation.
• Management: Awareness of a large, passive institutional holder, which typically implies stability in the shareholder base.

Next Steps

• Ongoing passive investment by The Vanguard Group in STAAR Surgical Co.

Key Dates

Keywords

STAAR Surgical Co, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Equity Stake, Passive Investment